PMIScience (@PMIScience) header
PMIScience (@PMIScience) profile picture

Explaining the science and innovation behind our #smokefree future.

Neuchâtel, Switzerland
Joined January 2015
Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)Photo by PMIScience (@PMIScience)
For Cam, a career in science has always been driven by a simple desire: to keep learning. As a clinical scientist specializing in safety surveillance, he helps ensure our smoke-free products meet regulatory requirements while building understanding of their safety profile. Today, technologies such as AI are creating new possibilities for scientific research, opening doors to faster insights and better outcomes. And as PMI continues to evolve and innovate, people like Cam are helping turn scientific progress into meaningful change. His drive and passion in life? Well, he says it best himself: “Curiosity has always been alive in my life.”
1
277
Aerosol vs smoke: two terms often used interchangeably, but they’re not the same. Hear from our Director External Scientific Assessment, Non-Clinical Science as he explains the difference, grounded in scientific evidence 👇
1
324
Science makes a difference when it’s communicated clearly. In this episode of My Life in Science, meet Jessica, a neuroscientist by training who now helps translate complex research into engaging stories that others can read, question, and build on.
1
1
2
351
Meet Helene, a Plant Testing Manager based at PMI’s greenhouse facility in Onnens, Switzerland. In this installment of My Life in Science, she shares her 18-year journey, what first inspired her to pursue a career in science, and what continues to motivate her today.
1
187
What is combustion, and why does it matter? Our Head of Combustion and Aerosol Science talks us through it. Sound on! 🔉
2
515
This week, we’ll be at the @GFNicotine in Warsaw for #GFN26. In this short teaser, our VP External Scientific Affairs, @GizelleBaker, and our Chief Medical Officer, Tryggve Ljung, preview one of the conversations we’ll be continuing at the conference: how evidence from longer-established product categories can inform discussions around newer ones 👇
1
4
277
Behind every study, every breakthrough, there are people driven by curiosity and purpose. Get to know our scientific community in our new series, My Life in Science. In this first episode, meet Tanja as she shares her journey from postdoc researcher to Senior Lab Scientist, and the key lessons she’s learned along the way.
2
157
As new tobacco and nicotine alternatives continue to be introduced, regulatory frameworks need to evolve just as quickly to reflect the latest scientific evidence. Around the world, some governments are beginning to recognize that science-based, differentiated regulations can better support adults who smoke by giving them access to scientifically substantiated alternatives. For more on the regulatory overview on smoke-free products 👉 spr.ly/6013B6hvVF
2
2
162
Valuable research, like PMI Science’s, can’t make a difference if it’s shut out. We need to evaluate the science, not suppress it—every scientific voice matters.
1
1
2
177
Better decisions are only possible when people have clear and scientifically accurate facts that cut through confusion. Because misconceptions about smoke-free products persist, we’re committed to strengthening transparency by openly sharing key scientific facts and figures behind our progress.
1
108
Behind our smoke-free vision is a diverse team of over 1,400 specialists dedicated to improving the way science serves society. At PMI Science, our community brings together a broad range of disciplines and collective expertise to advance our scientific research and drive meaningful innovation 👇
1
3
144
Misinformation can obscure scientific truth, creating false narratives that confuse the public and hinder the innovation needed for a better future. That’s why we continue to share our research findings and studies openly through resources like our PMI Science Booklet and Leaflet, reinforcing our commitment to transparency and integrity.
4
1
11
372
Through sharing our research openly, publishing peer-reviewed research, and continuously investing in innovation, we’re committed to turning data into dialogue and evidence into trust. This is what measurable progress looks like 👉 spr.ly/6017hdlWX
1
117
We’re proud of our extensive portfolio of patents, which reflects our ongoing investment in creating, scientifically substantiating, and commercializing smoke‑free products that offer adult smokers better alternatives to cigarettes. #SmokeFreeFuture #ResearchAndDevelopment
1
1
1
236
10 years of postmarket safety surveillance data. What have we learned? The 22nd issue of the Scientific Update showcases PMI’s commitment to monitor product safety after market release, highlighting the work of our safety surveillance team and sharing findings from the robust postmarket safety surveillance system established at PMI. Swipe to explore 👇
1
1
4
157
Sweden’s long-standing use of oral smokeless alternatives, like snus and more recently nicotine pouches, has contributed to the lowest smoking rate in Europe. This shift offers valuable insights for other countries exploring ways to reduce cigarette use. Discover the science and technology behind nicotine pouches here 👉 spr.ly/6010h3a2K #SwedishExperience #NicotinePouches #SmokeFreeFuture
2
2
13
1,161
What drives adult smokers to consider switching to smoke-free alternatives? We are using science to find the answers. Explore the full findings in our PMI Science Booklet: spr.ly/6017hyOC5 #PerceptionBehavior #RiskPerception #SmokeFreeAlternatives
1
1
2
247
Our goal is simple: to accelerate the end of smoking through science‑based innovation and transparent scientific communication. When science is open, progress is faster. Here’s more on some of the ways we make our research accessible, and encourage dialogue across the global scientific community👇
1
131
Majority of the toxicants in cigarette smoke originate from burning tobacco at high temperatures. By heating tobacco at low temperatures instead of burning it, our leading heated tobacco product emits an aerosol that contains significantly fewer and lower levels of toxicants compared with cigarette smoke. Find out more about the difference between smoke and aerosol 👉 spr.ly/6013C4ShL #HeatedTobacco #SmokeVsAerosol
3
185
Dr. Fischer, Manager of Regulatory Consumer Research at PMI, leads postmarket studies on the role of heated tobacco products (HTPs) in harm reduction. Her research, including a 6-year study in Japan, explores how millions of adult smokers have transitioned from cigarettes to HTPs—contributing to a continued decline in smoking prevalence. For her interview in full to explore her research on tobacco harm reduction 👉 spr.ly/6016C9Mbe
314